23andMe CEO Anne Wojcicki is seeking to take the personal genomics company private.Illustration: Alex Hogan/STAT, photo: Milken

Usually, introductory meetings with startup executives are perfunctory and fade to irrelevance within an hour. But I still remember the first moment I met 23andMe CEO and co-founder Anne Wojcicki in 2007.

My editor at the time had set up a meeting between my reporting partner and I and Wojcicki, along with 23andMe co-founder Linda Avey, at an upscale sandwich shop on East 13th Street in New York City. It was a hot day. Three of us were already chatting when Wojcicki careened in, began talking at a mile a minute, and unselfconsciously grabbed a glass of water from the table — my glass — and took a big sip.

advertisement

That moment has stuck in my head because it sums up so much about who Wojcicki has always been as she has lived what must be one of the 21st century’s most interesting lives, pinballing through a world of biology, high tech, and finance. She is someone who indefatigably but sometimes carelessly has managed to take what she needs, and given her dedication to her mission, it generally seems pretty much OK when she does so.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe